FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3190491649> ?p ?o ?g. }

• W3190491649 endingPage "1975" @default.
• W3190491649 startingPage "1975" @default.
• W3190491649 abstract "Drug resistance and tumor heterogeneity limits the therapeutic efficacy in treating glioblastoma, an aggressive infiltrative type of brain tumor. GBM cells develops resistance against chemotherapeutic agent, temozolomide (TMZ), which leads to the failure in treatment strategies. This enduring challenge of GBM drug resistance could be rational by combinatorial targeted therapy. Here, we evaluated the combinatorial effect of phenolic compound (2-(3,4-dihydroquinolin-1(2H)-yl)(p-tolyl)methyl)phenol (THTMP), GPR17 agonist 2-({5-[3-(Morpholine-4-sulfonyl)phenyl]-4-[4-(trifluoromethoxy)phenyl]-4H-1,2,4-triazol-3-yl}sulfanyl)-N-[4-(propan-2-yl)phenyl]acetamide (T0510.3657 or T0) with the frontline drug, TMZ, on the inhibition of GBM cells. Mesenchymal cell lines derived from patients’ tumors, MMK1 and JK2 were treated with the combination of THTMP + T0, THTMP + TMZ and T0 + TMZ. Cellular migration, invasion and clonogenicity assays were performed to check the migratory behavior and the ability to form colony of GBM cells. Mitochondrial membrane permeability (MMP) assay and intracellular calcium, [Ca2+]i, assay was done to comprehend the mechanism of apoptosis. Role of apoptosis-related signaling molecules was analyzed in the induction of programmed cell death. In vivo validation in the xenograft models further validates the preclinical efficacy of the combinatorial drug. GBM cells exert better synergistic effect when exposed to the cytotoxic concentration of THTMP + T0, than other combinations. It also inhibited tumor cell proliferation, migration, invasion, colony-forming ability and cell cycle progression in S phase, better than the other combinations. Moreover, the combination of THTMP + T0 profoundly increased the [Ca2+]i, reactive oxygen species in a time-dependent manner, thus affecting MMP and leading to apoptosis. The activation of intrinsic apoptotic pathway was regulated by the expression of Bcl-2, cleaved caspases-3, cytochrome c, HSP27, cIAP-1, cIAP-2, p53, and XIAP. The combinatorial drug showed promising anti-tumor efficacy in GBM xenograft model by reducing the tumor volume, suggesting it as an alternative drug to TMZ. Our findings indicate the coordinated administration of THTMP + T0 as an efficient therapy for inhibiting GBM cell proliferation." @default.
• W3190491649 created "2021-08-16" @default.
• W3190491649 creator A5026230936 @default.
• W3190491649 creator A5040475302 @default.
• W3190491649 creator A5056071671 @default.
• W3190491649 creator A5059431218 @default.
• W3190491649 creator A5059725933 @default.
• W3190491649 creator A5089531486 @default.
• W3190491649 date "2021-08-03" @default.
• W3190491649 modified "2023-10-07" @default.
• W3190491649 title "Alkylaminophenol and GPR17 Agonist for Glioblastoma Therapy: A Combinational Approach for Enhanced Cell Death Activity" @default.
• W3190491649 cites W1553898390 @default.
• W3190491649 cites W1607531254 @default.
• W3190491649 cites W1910239081 @default.
• W3190491649 cites W1932169383 @default.
• W3190491649 cites W1974254625 @default.
• W3190491649 cites W1976535263 @default.
• W3190491649 cites W1979795014 @default.
• W3190491649 cites W1996024251 @default.
• W3190491649 cites W2008757142 @default.
• W3190491649 cites W2014100516 @default.
• W3190491649 cites W2015100338 @default.
• W3190491649 cites W2015426350 @default.
• W3190491649 cites W2025183726 @default.
• W3190491649 cites W2034327787 @default.
• W3190491649 cites W2036406012 @default.
• W3190491649 cites W2039714430 @default.
• W3190491649 cites W2047865806 @default.
• W3190491649 cites W2066061824 @default.
• W3190491649 cites W2066571367 @default.
• W3190491649 cites W2074305443 @default.
• W3190491649 cites W2074618914 @default.
• W3190491649 cites W2081758137 @default.
• W3190491649 cites W2090563514 @default.
• W3190491649 cites W2096287682 @default.
• W3190491649 cites W2096439168 @default.
• W3190491649 cites W2103344286 @default.
• W3190491649 cites W2105100844 @default.
• W3190491649 cites W2113999599 @default.
• W3190491649 cites W2126275851 @default.
• W3190491649 cites W2132834292 @default.
• W3190491649 cites W2138545604 @default.
• W3190491649 cites W2141260882 @default.
• W3190491649 cites W2145869806 @default.
• W3190491649 cites W2161959295 @default.
• W3190491649 cites W2171237466 @default.
• W3190491649 cites W2293134842 @default.
• W3190491649 cites W2355732202 @default.
• W3190491649 cites W2598248281 @default.
• W3190491649 cites W2607167117 @default.
• W3190491649 cites W2735595873 @default.
• W3190491649 cites W2745429260 @default.
• W3190491649 cites W2768768130 @default.
• W3190491649 cites W2808979164 @default.
• W3190491649 cites W2925205243 @default.
• W3190491649 cites W2927066994 @default.
• W3190491649 cites W2997516063 @default.
• W3190491649 cites W3012300112 @default.
• W3190491649 cites W3096580267 @default.
• W3190491649 cites W3170646794 @default.
• W3190491649 doi "https://doi.org/10.3390/cells10081975" @default.
• W3190491649 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8393831" @default.
• W3190491649 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34440745" @default.
• W3190491649 hasPublicationYear "2021" @default.
• W3190491649 type Work @default.
• W3190491649 sameAs 3190491649 @default.
• W3190491649 citedByCount "4" @default.
• W3190491649 countsByYear W31904916492022 @default.
• W3190491649 countsByYear W31904916492023 @default.
• W3190491649 crossrefType "journal-article" @default.
• W3190491649 hasAuthorship W3190491649A5026230936 @default.
• W3190491649 hasAuthorship W3190491649A5040475302 @default.
• W3190491649 hasAuthorship W3190491649A5056071671 @default.
• W3190491649 hasAuthorship W3190491649A5059431218 @default.
• W3190491649 hasAuthorship W3190491649A5059725933 @default.
• W3190491649 hasAuthorship W3190491649A5089531486 @default.
• W3190491649 hasBestOaLocation W31904916491 @default.
• W3190491649 hasConcept C185592680 @default.
• W3190491649 hasConcept C190283241 @default.
• W3190491649 hasConcept C2776999253 @default.
• W3190491649 hasConcept C2777389519 @default.
• W3190491649 hasConcept C2778227246 @default.
• W3190491649 hasConcept C31573885 @default.
• W3190491649 hasConcept C502942594 @default.
• W3190491649 hasConcept C55493867 @default.
• W3190491649 hasConcept C71924100 @default.
• W3190491649 hasConcept C98274493 @default.
• W3190491649 hasConceptScore W3190491649C185592680 @default.
• W3190491649 hasConceptScore W3190491649C190283241 @default.
• W3190491649 hasConceptScore W3190491649C2776999253 @default.
• W3190491649 hasConceptScore W3190491649C2777389519 @default.
• W3190491649 hasConceptScore W3190491649C2778227246 @default.
• W3190491649 hasConceptScore W3190491649C31573885 @default.
• W3190491649 hasConceptScore W3190491649C502942594 @default.
• W3190491649 hasConceptScore W3190491649C55493867 @default.
• W3190491649 hasConceptScore W3190491649C71924100 @default.
• W3190491649 hasConceptScore W3190491649C98274493 @default.
• W3190491649 hasFunder F4320321108 @default.

• next